Analyzing...
Loading company...
Nothing flagged for monitoring
“Operates in Chemicals — Specialty & Commodity.”
₹778 Cr revenue.
COGS 54.4%, employees 8.3%.
“anticipate mechanical completion before end of this year, commence trial production followed by commercial production in Q1 FY27 (April 2026)”
“We are very confident that '27, there will be a very strong demand, and we should see a demand improvement in h1 FY twenty seven. But FY twenty six did not pan out the way we had envisioned”
“Next year, when we hit full utilization $9.50 to 1,000 crore on standalone basis, we expect the same 18% plus or minus 1.5% kind of margin.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 2.5%▼ | 7.6% |
| ROCE | 6.5%▼ | 10.9% |
| Net Margin | 2.4%▼ | 5.1% |
| EBITDA Margin | 14.7%▲ | 12.1% |
| Debt To Equity | 1.35x▲ | 0.20x |
| Rev Growth 3yr | 17.0%▲ | 5.9% |
| EPS Growth 3yr | -9.7%▼ | -9.4% |
Historical valuation data not available.
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹818 Cr +5.2% | ₹778 Cr +12.6% | ₹691 Cr +0.7% | ₹686 Cr +40.8% | ₹487 Cr +44.8% | ₹336 Cr +9.9% | ₹306 Cr +28.1% | ₹239 Cr |
| Other Income | ₹6 Cr +43.4% | ₹4 Cr -46.3% | ₹7 Cr +67.9% | ₹4 Cr +315.9% | ₹1 Cr +674.8% | ₹0.14 Cr +39.2% | ₹0.10 Cr -80.4% | ₹0.51 Cr |
| Total Income | ₹824 Cr +5.4% | ₹782 Cr +12.0% | ₹698 Cr +1.1% | ₹691 Cr +41.4% | ₹488 Cr +45.1% | ₹337 Cr +9.9% | ₹306 Cr +27.8% | ₹240 Cr |
| COGS | ₹437 Cr +3.3% | ₹423 Cr +10.6% | ₹382 Cr -1.5% | ₹389 Cr +41.3% | ₹275 Cr +39.1% | ₹198 Cr +7.3% | ₹184 Cr +30.9% | ₹141 Cr |
| ₹781 Cr +8.9% | ₹718 Cr +11.2% | ₹646 Cr +4.2% | ₹620 Cr +43.6% | ₹431 Cr +47.4% | ₹293 Cr +10.4% | ₹265 Cr +26.1% | ₹210 Cr | |
| Profit Before Tax | ₹29 Cr -42.8% | ₹50 Cr -5.0% | ₹53 Cr -25.9% | ₹71 Cr +24.7% | ₹57 Cr +29.8% | ₹44 Cr +6.6% | ₹41 Cr +40.5% | ₹29 Cr |
| Exceptional Items | (₹14 Cr) 0.0% | (₹14 Cr) | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr -100.0% | ₹0.11 Cr +8.8% | ₹0.10 Cr |
| ₹9 Cr -40.3% | ₹15 Cr -10.5% | ₹17 Cr -18.7% | ₹21 Cr +69.3% | ₹12 Cr -3.4% | ₹13 Cr +3.6% | ₹12 Cr +49.7% | ₹8 Cr | |
| Net Profit | ₹20 Cr -43.4% | ₹35 Cr -2.3% | ₹36 Cr -28.7% | ₹50 Cr +12.0% | ₹45 Cr +42.4% | ₹31 Cr +9.3% | ₹29 Cr +36.8% | ₹21 Cr |
| Profit (Owners) | ₹20 Cr -43.4% | ₹35 Cr -2.3% | ₹36 Cr -28.7% | ₹50 Cr +12.0% | ₹45 Cr +42.4% | ₹31 Cr +9.3% | ₹29 Cr +36.8% | ₹21 Cr |
| Other Comprehensive Income | (₹0.29 Cr) +34.1% | (₹0.44 Cr) +26.7% | (₹0.60 Cr) ↓ Decline | ₹0.28 Cr ↑ Recovery | (₹0.28 Cr) ↓ Decline | ₹0.06 Cr ↑ Recovery | (₹0.53 Cr) ↓ Decline | ₹0.10 Cr |
| EPS | ₹7.48 | ₹13.20 | ₹13.51 | ₹20.04 | ₹17.90 | ₹13.43 | ₹12.28 | ₹10.43 |
| Diluted Shares | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| Profit Or Loss Of Associates | ₹0.30 Cr +50.0% | ₹0.20 Cr +11.1% | ₹0.18 Cr +80.0% | ₹0.10 Cr -44.4% | ₹0.18 Cr -53.7% | ₹0.39 Cr | ₹0.00 Cr | ₹0.00 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Neogen Chemicals Limited has informed the Exchange about Schedule of meet
Neogen Chemicals Limited has informed the Exchange about Transcript
Neogen Chemicals Limited has informed the Exchange about Schedule of meet
Neogen Chemicals Limited has informed the Exchange regarding allotment of 10,00,000 equity shares pursuant to Preferential Issue at its Fund Raising Committee meeting held on April 18, 2026
Neogen Chemicals Limited has informed the Exchange regarding Outcome of Committee Meeting held on April 18, 2026 - Allotment of 10,00,000 equity shares.
Neogen Chemicals Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on March 29, 2026
Neogen Chemicals Limited has informed the Exchange about Copy of Newspaper Publication - Corrigendum to Notice of EGM.
Neogen Chemicals Limited has informed the Exchange about Copy of Newspaper Publication.
Neogen Chemicals Limited has informed the Exchange about Book closure dates.
Neogen Chemicals Limited has informed the Exchange that Record date for the purpose of Preferential Offer / Notice of EGM and other timelines.
Neogen Chemicals Limited has informed the Exchange Notice of Extra Ordinary General meeting to be held on 29-03-2026 at 11.30 a.m.
Neogen Chemicals Limited has informed the Exchange about Outcome of board meeting approving issue of 10,00,000 equity shares on preferential issue basis and approving Notice of EGM and related timelin...
Neogen Chemicals Limited has informed the Exchange about Outcome of board meeting approving issue of 10,00,000 equity shares on preferential issue basis and approving Notice of EGM and related timelin...
Neogen Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 07, 2026.
Neogen Chemicals Limited has informed the Exchange about Schedule of meet